Nuvation Bio Inc.
HETEROCYCLIC COMPOUNDS AS BET INHIBITORS

Last updated:

Abstract:

Novel bromodomain and extraterminal domain (BET) inhibitors and to therapeutic methods of treating conditions and diseases using these novel BET inhibitors are provided.

Status:
Application
Type:

Utility

Filling date:

30 Oct 2019

Issue date:

7 May 2020